Tanakan tablets 40mg, No. 90

cognitive and neurosensory deficits of various origins (with the exception of Alzheimer's disease and dementia of various etiologies);

intermittent claudication in chronic obliterating arteriopathies of the lower extremities (2nd degree according to Fontaine);

visual impairment of vascular origin, a decrease in its acuity;

hearing impairment, ringing in the ears, dizziness and coordination disorders, predominantly of vascular origin;

Raynaud's disease and syndrome.

Inside, during meals.

1 table. or 1 ml of solution 3 times a day. The oral solution should be pre-dissolved in 1/2 glass of water. The tablets must be taken with 1/2 glass of water.

When taking the drug in the form of a solution for oral administration, use the supplied pipette-dispenser (1 dose = 1 ml of solution).

The minimum course of treatment is 3Ц6 months. For tablets, the course of treatment is at least 3 months. An increase in the duration and repeated courses of treatment is possible on the recommendation of a doctor.

hypersensitivity to any component of the drug;

erosive gastritis in the acute stage;

peptic ulcer of the stomach and duodenum in the acute stage;

acute disorders of cerebral circulation;

acute myocardial infarction;

decreased blood clotting;

pregnancy;

lactation period;

age up to 18 years.

Since the drug in the form of tablets contains lactose, it should not be prescribed to patients with congenital galactosemia, glucose or galactose malabsorption syndrome, lactose intolerance or lactase deficiency.

Since the drug in the form of a solution contains 0.45 g of ethyl alcohol per dose (one dose), it should be prescribed with caution to patients with alcoholism, liver diseases, TBI and brain diseases.

Indications for use:
cognitive and neurosensory deficits of various origins (with the exception of Alzheimer's disease and dementia of various etiologies);
intermittent claudication in chronic obliterating arteriopathy of the lower extremities (grade 2 according to Fontaine);
visual impairment of vascular origin, decrease in its acuity;
hearing impairment, tinnitus, dizziness and movement coordination disorders, predominantly of vascular origin;
Raynaud's disease and syndrome.

Contraindications:
Age up to 18 years.
Hypersensitivity to any of the drug's components, erosive gastritis in the acute stage, gastric ulcer and duodenal ulcer in the acute stage, acute cerebrovascular accidents, acute myocardial infarction, congenital galactosemia, lactase deficiency, lactose intolerance, glucose malabsorption, low blood ...
EFFECTS ON DRIVING MOTOR VEHICLES AND CONTROL OF MECHANISMS
During the period of taking the drug, it is not recommended to perform potentially hazardous activities that require increased concentration of attention and speed of psychomotor reactions (including driving, working with moving mechanisms), because the drug may cause dizziness.
APPLICATION DURING PREGNANCY AND DURING BREASTFEEDING
Due to the lack of clinical data on the use of the drug during pregnancy and breastfeeding, the appointment of the drug to this group of patients is contraindicated.

Overdose:
To date, no cases of overdose have been reported.

Side effects:
Possible allergic reactions (redness, skin rash, swelling, itching, urticaria), decreased blood clotting and the possibility of bleeding (with prolonged use), eczema, headache, dizziness, tinnitus, gastrointestinal disorders (nausea, vomiting, abdominal pain, dyspepsia, diarrhea).
In case of any undesirable phenomena, the drug should be discontinued and consult your doctor.

Special instructions:
Before using the drug, a doctor's consultation is required.
Improvement of the condition appears 1 month after the start of treatment.

Dosage regimen: For
adults, 1 tablet 3 times a day with meals.
The tablet must be taken with 1/2 glass of water.
The course of treatment is at least 3 months. An increase in the duration and repeated courses of treatment is possible on the recommendation of a doctor.